Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel E Bertrand

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 30, 2007
The shorter the better?Michel E Bertrand
Methodist Debakey Cardiovascular Journal|April 15, 2011
What are the current risks of cardiac catheterization?Michel E Bertrand
Current Medical Research and Opinion|October 7, 2004
Provision of cardiovascular protection by ACE inhibitors: a review of recent trialsMichel E Bertrand
Journal of the American College of Cardiology|October 18, 2003
Cardiogenic shock: is there light at the end of the tunnel?Michel E Bertrand, Eugene McFadden
European Heart Journal|December 25, 2007
Non-ST-segment elevation acute coronary syndromes: an algorithm for decisionMichel E Bertrand, Jean Philippe Collet, Gilles Montalescot
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 4, 2016
Triple Combination Therapy for Global Cardiovascular Risk: Atorvastatin, Perindopril, and AmlodipineMichel E Bertrand, Charalambos Vlachopoulos, Jean-Jacques Mourad
Coronary Artery Disease|December 2, 2005
Nature of coronary disease in patients with insulin resistance and its impact on revascularization strategiesEric Van Belle, Christophe Bauters, Eugène McFadden, et al.
Journal of the American College of Cardiology|August 15, 2006
A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast mediaPeter A McCullough, Michel E Bertrand, Jeffrey A Brinker, et al.
American Heart Journal|December 19, 2015
Perindopril and β-blocker for the prevention of cardiac events and mortality in stable coronary artery disease patients: A EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) subanalysisMichel E Bertrand, Roberto Ferrari, Willem J Remme, et al.
Archives of Cardiovascular Diseases|March 24, 2009
Angiotensin-converting enzyme inhibition with perindopril in patients with prior myocardial infarction and/or revascularization: a subgroup analysis of the EUROPA trialMichel E Bertrand, Kim M Fox, Willem J Remme, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 30, 2007
The shorter the better?Michel E Bertrand
Methodist Debakey Cardiovascular Journal|April 15, 2011
What are the current risks of cardiac catheterization?Michel E Bertrand
Current Medical Research and Opinion|October 7, 2004
Provision of cardiovascular protection by ACE inhibitors: a review of recent trialsMichel E Bertrand
Journal of the American College of Cardiology|October 18, 2003
Cardiogenic shock: is there light at the end of the tunnel?Michel E Bertrand, Eugene McFadden
European Heart Journal|December 25, 2007
Non-ST-segment elevation acute coronary syndromes: an algorithm for decisionMichel E Bertrand, Jean Philippe Collet, Gilles Montalescot
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 4, 2016
Triple Combination Therapy for Global Cardiovascular Risk: Atorvastatin, Perindopril, and AmlodipineMichel E Bertrand, Charalambos Vlachopoulos, Jean-Jacques Mourad
Coronary Artery Disease|December 2, 2005
Nature of coronary disease in patients with insulin resistance and its impact on revascularization strategiesEric Van Belle, Christophe Bauters, Eugène McFadden, et al.
Journal of the American College of Cardiology|August 15, 2006
A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast mediaPeter A McCullough, Michel E Bertrand, Jeffrey A Brinker, et al.
American Heart Journal|December 19, 2015
Perindopril and β-blocker for the prevention of cardiac events and mortality in stable coronary artery disease patients: A EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) subanalysisMichel E Bertrand, Roberto Ferrari, Willem J Remme, et al.
Archives of Cardiovascular Diseases|March 24, 2009
Angiotensin-converting enzyme inhibition with perindopril in patients with prior myocardial infarction and/or revascularization: a subgroup analysis of the EUROPA trialMichel E Bertrand, Kim M Fox, Willem J Remme, et al.
Pageof 6